Heart disease, type 2 diabetes, obesity, kidney disease and other cardiometabolic-related disorders are increasing in prevalence and placing a financial and workforce strain on the medical system.
Providers have been trained to treat these conditions within their respective specialty; patients with diabetes are treated by endocrinologists, those with heart disease are treated by cardiologists, and so on. But this siloed care model is inefficient, expensive, and becoming outdated as we learn more about the interrelatedness of these conditions. For example, the leading cause of death in patients with type 2 diabetes is heart disease.
Because of the increased understanding of the complex relationship between cardiometabolic decline and overall health, there is an imminent need for a new method of care. Cardiometabolic Health Congress (CMHC) and its partners support the development of a cardiometabolic specialty dedicated to comprehensive care for patients with these risk factors and conditions, that will treat the patient as a whole person instead of a cluster of symptoms.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.